A
Price
$143.06
Change
+$4.05 (+2.91%)
Updated
Sep 19, 10:28 AM (EDT)
60 days until earnings call
AORT
Price
$25.23
Change
+$0.26 (+1.04%)
Updated
Sep 19, 09:39 AM (EDT)
42 days until earnings call
Ad is loading...

A vs AORT

Header iconA vs AORT Comparison
Open Charts A vs AORTBanner chart's image
Agilent Technologies
Price$143.06
Change+$4.05 (+2.91%)
Volume$1.64K
CapitalizationN/A
Artivion
Price$25.23
Change+$0.26 (+1.04%)
Volume$500
CapitalizationN/A
View a ticker or compare two or three
A vs AORT Comparison Chart
Loading...
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
AORT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
A vs. AORT commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a StrongBuy and AORT is a Hold.

COMPARISON
Comparison
Sep 19, 2024
Stock price -- (A: $139.01 vs. AORT: $24.97)
Brand notoriety: A and AORT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: A: 92% vs. AORT: 84%
Market capitalization -- A: $42.66B vs. AORT: $873.56M
A [@Medical Specialties] is valued at $42.66B. AORT’s [@Medical Specialties] market capitalization is $873.56M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 1 FA rating(s) are green whileAORT’s FA Score has 0 green FA rating(s).

  • A’s FA Score: 1 green, 4 red.
  • AORT’s FA Score: 0 green, 5 red.
According to our system of comparison, A is a better buy in the long-term than AORT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 5 TA indicator(s) are bullish while AORT’s TA Score has 3 bullish TA indicator(s).

  • A’s TA Score: 5 bullish, 2 bearish.
  • AORT’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, A is a better buy in the short-term than AORT.

Price Growth

A (@Medical Specialties) experienced а +0.22% price change this week, while AORT (@Medical Specialties) price change was +2.63% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.94%. For the same industry, the average monthly price growth was +1.41%, and the average quarterly price growth was -2.55%.

Reported Earning Dates

A is expected to report earnings on Nov 18, 2024.

AORT is expected to report earnings on Oct 31, 2024.

Industries' Descriptions

@Medical Specialties (+1.94% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
A($42.7B) has a higher market cap than AORT($874M). AORT has higher P/E ratio than A: AORT (434.78) vs A (34.82). AORT YTD gains are higher at: 39.653 vs. A (0.334). A has higher annual earnings (EBITDA): 1.69B vs. AORT (26.8M). AORT has less debt than A: AORT (358M) vs A (2.56B). A has higher revenues than AORT: A (6.74B) vs AORT (354M).
AAORTA / AORT
Capitalization42.7B874M4,886%
EBITDA1.69B26.8M6,306%
Gain YTD0.33439.6531%
P/E Ratio34.82434.788%
Revenue6.74B354M1,903%
Total CashN/A58.9M-
Total Debt2.56B358M714%
FUNDAMENTALS RATINGS
A vs AORT: Fundamental Ratings
A
AORT
OUTLOOK RATING
1..100
2267
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
93
Overvalued
PROFIT vs RISK RATING
1..100
34100
SMR RATING
1..100
4091
PRICE GROWTH RATING
1..100
5343
P/E GROWTH RATING
1..100
6582
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

A's Valuation (21) in the Biotechnology industry is significantly better than the same rating for AORT (93) in the Medical Specialties industry. This means that A’s stock grew significantly faster than AORT’s over the last 12 months.

A's Profit vs Risk Rating (34) in the Biotechnology industry is significantly better than the same rating for AORT (100) in the Medical Specialties industry. This means that A’s stock grew significantly faster than AORT’s over the last 12 months.

A's SMR Rating (40) in the Biotechnology industry is somewhat better than the same rating for AORT (91) in the Medical Specialties industry. This means that A’s stock grew somewhat faster than AORT’s over the last 12 months.

AORT's Price Growth Rating (43) in the Medical Specialties industry is in the same range as A (53) in the Biotechnology industry. This means that AORT’s stock grew similarly to A’s over the last 12 months.

A's P/E Growth Rating (65) in the Biotechnology industry is in the same range as AORT (82) in the Medical Specialties industry. This means that A’s stock grew similarly to AORT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AAORT
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
74%
Momentum
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
70%
MACD
ODDS (%)
Bearish Trend 1 day ago
58%
Bearish Trend 1 day ago
75%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
61%
Bearish Trend 1 day ago
68%
Advances
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
Bearish Trend 16 days ago
55%
Bearish Trend 1 day ago
70%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
77%
Aroon
ODDS (%)
Bullish Trend 1 day ago
69%
Bearish Trend 4 days ago
67%
View a ticker or compare two or three
Ad is loading...
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
AORT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BKSY5.860.24
+4.27%
BlackSky Technology Inc
UAN69.960.35
+0.50%
CVR Partners LP
WBA9.01-0.06
-0.61%
Walgreens Boots Alliance
VC92.38-1.19
-1.27%
Visteon Corp
ISPO4.60-0.19
-3.97%
Inspirato

AORT and

Correlation & Price change

A.I.dvisor indicates that over the last year, AORT has been loosely correlated with WAT. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if AORT jumps, then WAT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AORT
1D Price
Change %
AORT100%
-0.99%
WAT - AORT
44%
Loosely correlated
+1.34%
SIBN - AORT
43%
Loosely correlated
N/A
KIDS - AORT
41%
Loosely correlated
-3.28%
A - AORT
41%
Loosely correlated
+0.48%
ESTA - AORT
40%
Loosely correlated
-2.87%
More